The Federal Trade Commission said pharmacy benefit managers created a "perverse drug rebate system" that artificially ...

In January, a new Idaho law will take effect requiring reform of business practices by pharmacy middlemen — in search of tamping down prescription drug costs. The new law targets pharmacy benefit ...

The agency alleges CVS’s Caremark, Cigna’s Express Scripts and UnitedHealth’s Optum Rx accepted money from drugmakers in ...

However, the Federal Trade Commission (FTC) staff has issued a report that focuses on those income claims made by 70 MLM companies. In the report, the FTC staff found many issues with the income ...

For example, CVS Caremark — the largest PBM with 34% market share, according to the Federal Trade Commission (FTC) — is part of the CVS Health Corporation, which also includes the company’s ...

In 2023, consumers reported $114 million in losses from scams involving BTMs — a nearly 900% increase over the preceding three years, the FTC said Tuesday in a report. Losses through June of ...

The FTC said it has agreed to a $2.95 million settlement package with Verkada, which includes acknowledgement that Verkada spammed its own customers with junk email and allowed them to be exposed ...

In January 2023, the Federal Trade Commission (FTC) issued a proposed rule that would ban most noncompete agreements throughout the United States. After receiving more than 26,000 public comments ...

On April 23, 2024, the FTC announced the issuance of a final rule banning employers from entering into, enforcing, or attempting to enforce post-employment non-compete clauses, subject to limited ...

Momentum is growing for PBM regulation. In 2022, the FTC launched an investigation into PBMs’ role in drug pricing. This July, it released a scathing interim report, calling PBMs middlemen who “profit ...

On August 20, 2024, the Federal Trade Commission (FTC) filed a comment letter in support of the Food and Drug Administration’s (FDA’s) June 2024 draft guidance on biosimilar interchangeability ...

In July, the FTC released the results of its investigation ... Collectively, they control 80% of the PBM market. All three are also part of large, vertically integrated healthcare companies.